Developmental BiologybioRxivPreprint
Mesenchymal expression of activated K-ras yields Noonan Syndrome-like bone defects that are rescued by mid-gestational MEK inhibition.
Simona Nedelcu, Tatsuya Kobayashi, Monica Stanciu…·Jacqueline A. Lees
This paper generates a mouse model with activated K-ras in mesenchymal progenitors to study Noonan Syndrome-like bone defects and shows that MEK inhibition during mid-gestation rescues these defects.
DOI 10.1101/634840